Table 1 Characteristics of the sample of patients with type 2 diabetes (n = 2,642)
| Ā | Total | Men | Women | p value |
|---|---|---|---|---|
Age, years; mean (SD) | 68.06 (11.60) | 66.81 (11.63) | 69.31 (11.59) | < 0.001 |
Gender,n (%) | 2642 | 1361 (51.5) | 1281(48.5) | ns |
Years of diabetes duration, mean (SD) | 7.05 (5.60) | 6.58 (5.06) | 7.39 (6.04) | <0.001 |
Diabetes duration 5ā10 years, n (%) | 803 (30.4) | 413 (30.4) | 390 (30.5) | ns |
Diabetes duration & 10 years, n (%) | 497 (18.8) | 231 (17.0) | 266 (20.8) | < 0.05 |
BP, mmHg,mean (SD) | 137.23/76.52 (14.60/9.05) | 136.98/76.49 (14.68/9.10) | 137.08/76.43 (14.71/8.89) | ns SBP ns DBP |
Hypertension,n (%) | 1847 (69.9) | 894 (65.6) | 953 (74.3) | <0.001 |
BP ā¤ 140/90 mmHg,n (%) | 1896 (71.7) | 976 (71.7) | 920 (71.8) | ns |
BP ā¤ 130/80 mmHg,n (%) | 915 (34.6) | 460 (33.8) | 455 (35.5) | ns |
HbA1c, mean (SD) | 6.84 (1.46) | 6.83 (1.47) | 6.85 (1.44) | ns |
HbA1c ā¤ 7%, n (%) | 1786 (67.6) | 920 (67.6) | 866 (67.6) | ns |
HbA1c ā¤ 8%,n (%) | 2319 (87.7) | 1182 (86.8) | 1137 (88.7) | ns |
Total cholesterol,mg/dl,mean (SD) | 194.33 (38.41) | 188.06 (38.45) | 201.00 (37.25) | <0.001 |
Non-HDL cholesterol, mg/dl,mean (SD) | 144,10 (37.44) | 140.63 (37.72) | 148.10 (36.65) | <0.001 |
Non-HDL cholesterol < 130 mg/dl, n (%) | 1007 (38.1) | 592 (43.5) | 415 (32.4) | <0.001 |
Non-HDL cholesterol < 160 mg/dl, n (%) (1) | 1802 (68.2) | 957 (70.3) | 845 (66.0) | 0.025 |
Obesity, n (%) | 1118 (42.3) | 471 (34.6) | 647 (50.5 | <0.001 |
Tobacco habit, n (%) | 365 (13.8) | 299 (22.0) | 66 (5.1) | <0.001 |
Creatinine, mg/dl (SD) | 1.21 (1.03) | 1.30 (1.12) | 1.10 (0.92) | <0.001 |
GFR, mil/min/1.73 m2 (SD) | 76.30 (32.79) | 79.73 (29.48) | 72.71 (35.67) | <0.001 |
Macrovascular disease,n (%) (1) | 460 (17.4) | 275 (20.2) | 185 (14.4) | <0.001 |
CHD,n (%) | 329 (12.4) | 197 (14.5) | 132 (10.3) | 0.014 |
Stroke,n (%) | 188 (7.1) | 102 (7.5) | 86 (6.7) | ns |
Diabetic foot, n (%) (2) | 100 (5.0) | 48 (4.6) | 52 (5.3) | ns |
Microvascular disease (3) | 475 (32.1) | 260 (34.1) | 215 (30.0) | ns |
Albuminuria, n (%) (3) | 288 (19.5) | 184 (24.1) | 104 (14.5) | <0.001 |
Diabetic retinopathy, n (%) | 227(15.3) | 113 (14.8) | 114 (16.0) | ns |
ACEI/ARB treatment, n (%) | 1453 (54.9) | 741 (54.5) | 712 (55.5) | ns |
Calibrated Framingham cardiovascular risk equation & 10%, n (%) | 240 (9.1) | 194 (14.2) | 46 (3.6) | <0.001 |